AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$PLUS

RAIGUEL DARREN S sold $80K of PLUS (indirect holdings)

RAIGUEL DARREN S (CHIEF OPERATING OFFICER) sold 854 indirectly-held shares of EPLUS INC (PLUS) at an average of $93.14 ($93.11–$93.18) across 2 trades over 2026-09-14 to 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RAIGUEL DARREN S
Published Sep 16, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PLUS
Neutral
high confidence
Mentioned
$PLUS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLUSNeutralLow
01

Why it matters

Routine insider sale with limited market relevance.

02

Market read

Low relevance; typical disclosure with minimal trading implication.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 2/10Novelty 4/10Timing: filed Sep 16 2026

Background

Form 4 filing reports insider transactions required by SEC.

Company-level read

Ticker impact

$PLUSNeutralHigh confidence
Context

Chief Operating Officer Raiguel Darren S sold 854 shares for $79,543 via a 10b5-1 plan.

Expected impact

No material move expected.

Evidence & confidence

The transaction size is small relative to market cap and was pre‑arranged.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Even small insider sales can signal confidence issues.

Key entities

  • company
    EPLUS INC

    Issuer of the Form 4 filing.

  • person
    Raiguel Darren S

    Chief Operating Officer of EPLUS INC.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PLUS insider trading history →

Related articles

AUG 24
$CDWMedAI 8/10

Q2 Earnings Outperformers: CDW (NASDAQ:CDW) And The Rest Of The IT Distribution & Solutions Stocks

CDW, ePlus, TD SYNNEX, and ScanSource reported Q2 earnings. CDW (-6%) and ePlus (-10.5%) saw stock declines, while ScanSource (+5.5%) rose. TD SYNNEX (-10.5%) reported strong revenue growth but also fell. ePlus reported flat revenue but beat EPS estimates. ScanSource had the largest analyst estimate beat. TD SYNNEX reported $19.57B revenue, up 31% YoY, and beat EPS estimates and guidance.

yahoo.com3 min
AUG 10
$PLUSMed

Plus500 increases buybacks as US growth continues

Plus500 said it will increase shareholder returns via buybacks alongside its half-year results. The company reported double-digit revenue growth year over year and Ebitda up 1% to $188mn. It attributed a lower Ebitda margin (45% to 41%) to higher marketing spend to attract new customers, while expanding in US futures.

investorschronicle.co.uk3 min
AUG 5
$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.

financialcontent.com4 min